Lionco Pharm Grp Co Ltd Tangible Net Worth Ratio
Lionco Pharm Grp Co Ltd tangible net worth ratio. Lionco Pharm Grp Co Ltd (603669) has a Tangible Net Worth Ratio of 85.9% as of June 2026. This metric is calculated by deducting intangible assets (CN¥90.39 Million) from net assets (CN¥641.40 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of Lionco Pharm Grp Co Ltd to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Lionco Pharm Grp Co Ltd (2011–2025)
Tangible net worth ratio of Lionco Pharm Grp Co Ltd from 2011 to 2025. This chart shows how Lionco Pharm Grp Co Ltd's Tangible Net Worth Ratio has changed across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 85.9%, reflecting net assets of CN¥641.40 Million with intangible assets of CN¥90.39 Million CNY. Check how strategically is Lionco Pharm Grp Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Lionco Pharm Grp Co Ltd Tangible Net Worth Ratio by Year (2011–2025)
Lionco Pharm Grp Co Ltd tangible net worth ratio by year from 2011 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Lionco Pharm Grp Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market cap of Lionco Pharm Grp Co Ltd.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 84.9% | CN¥620.28 Million | CN¥93.61 Million | CN¥1.11 Billion | ▼ -2.0 pp |
| 2024 | 86.9% | CN¥769.76 Million | CN¥100.90 Million | CN¥1.26 Billion | ▼ -1.5 pp |
| 2023 | 88.4% | CN¥931.04 Million | CN¥108.44 Million | CN¥1.62 Billion | ▼ -1.4 pp |
| 2022 | 89.8% | CN¥1.14 Billion | CN¥115.79 Million | CN¥1.86 Billion | ▼ -1.7 pp |
| 2021 | 91.5% | CN¥1.46 Billion | CN¥124.10 Million | CN¥2.51 Billion | ▼ -1.6 pp |
| 2020 | 93.1% | CN¥1.48 Billion | CN¥102.70 Million | CN¥2.72 Billion | ▼ -3.1 pp |
| 2019 | 96.2% | CN¥1.31 Billion | CN¥50.50 Million | CN¥1.91 Billion | ▼ -0.4 pp |
| 2018 | 96.6% | CN¥1.38 Billion | CN¥47.52 Million | CN¥2.07 Billion | ▼ 0.0 pp |
| 2017 | 96.6% | CN¥1.30 Billion | CN¥44.41 Million | CN¥1.65 Billion | ▲ +0.5 pp |
| 2016 | 96.1% | CN¥1.17 Billion | CN¥45.45 Million | CN¥1.34 Billion | ▲ +0.2 pp |
| 2015 | 95.9% | CN¥1.12 Billion | CN¥46.15 Million | CN¥1.34 Billion | ▲ +8.4 pp |
| 2014 | 87.4% | CN¥374.13 Million | CN¥47.02 Million | CN¥559.83 Million | ▼ -4.6 pp |
| 2013 | 92.1% | CN¥351.02 Million | CN¥27.81 Million | CN¥582.12 Million | ▼ -2.8 pp |
| 2012 | 94.8% | CN¥236.22 Million | CN¥12.22 Million | CN¥364.89 Million | ▲ +11.0 pp |
| 2011 | 83.8% | CN¥128.55 Million | CN¥20.84 Million | CN¥244.38 Million | — |